SLNO
Soleno Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$33.76
-2.98 ▼ -8.12%
🌙 3월 13일 7:39 PM ET (한국 3/14 08:39)
$33.86
+0.11 ▲ +0.32%
| Index | RUT | P/E | 151.44 | EPS (ttm) | 0.22 | Insider Own | 3.96% | Shs Outstand | 0.05B | Perf Week | -14.93% |
| Market Cap | 1.74B | Forward P/E | 4.91 | EPS next Y | 70.07% | Insider Trans | - | Shs Float | 0.05B | Perf Month | -15.72% |
| Enterprise Value | 1.49B | PEG | 0.02 | EPS next Q | 0.67 | Inst Own | 125.44% | Short Float | 17.89% | Perf Quarter | -32.49% |
| Income | 0.02B | P/S | 9.15 | EPS this Y | 936.88% | Inst Trans | -1.27% | Short Ratio | 5.85 | Perf Half Y | -40.49% |
| Sales | 0.19B | P/B | 3.92 | EPS next 5Y | 196.57% | ROA | 4.58% | Short Interest | 8.87M | Perf YTD | -27.1% |
| Book/sh | 8.61 | P/C | 5.7 | EPS past 3/5Y | - | ROE | 5.89% | 52W High | -62.63% ($90.32) | Perf Year | -31.15% |
| Cash/sh | 5.92 | P/FCF | 37.35 | Sales past 3/5Y | - | ROIC | 4.08% | 52W Low | 3.45% ($32.63) | Perf 3Y | 1587.75% |
| Dividend Est. | - | EV/EBITDA | 87.78 | EPS Y/Y TTM | 105.97% | Gross Margin | 98.32% | Volatility(W/M) | 6.32% 6.51% | Perf 5Y | 46.13% |
| Dividend TTM | - | EV/Sales | 7.82 | Sales Y/Y TTM | - | Oper. Margin | 7.85% | ATR (14) | 2.45 | Perf 10Y | -60.86% |
| Dividend Ex-Date | - | Quick Ratio | 5.55 | EPS Q/Q | 162.02% | Profit Margin | 10.75% | RSI (14) | 32.28 | Recom | 1.08 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.8 | Sales Q/Q | - | SMA20 | -12.69% ($38.67) | Beta | -2.93 | Target Price | $107.46 |
| Payout | - | Debt/Eq | 0.12 | Earnings | 2000000 | SMA50 | -17.69% ($41.02) | Rel Volume | 2.56 | Prev Close | $36.74 |
| Employees | 182 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | 12.55% 3.36% | SMA200 | -44.1% ($60.39) | Avg Volume(3M) | 1.52M | Price | $33.76 |
| IPO | 2014/11/13 | Option/Short | Yes/Yes | Trades | 33889 | Volume | 3,879,038 | Change | -8.12% |
뉴스 로딩 중...